CliffBio
small molecule

NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE

HYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

Loss of exclusivity—loss of exclusivity
CompanySAPTALIS PHARMACEUTICALS LLC

Drug detail

Brand nameNEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE
Active ingredientHYDROCORTISONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
Strength1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
Dosage formSOLUTION/DROPS
RouteOTIC
ModalitySmall molecule
FDA approvalOctober 2005
Marketing statusDISCN

More from SAPTALIS PHARMACEUTICALS LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE patent cliff — loss of exclusivity — | CliffBio